Physician profile
David A Hanley
NPI 1083830715
$3,612.76
in general payments reported to CMS, 2019-2025
9 companies · $190 in 2025
The $190 reported for 2025 was more than what 80% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,905 · 2022: $293 · 2023: $372 · 2024: $853 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,249 · Travel and Lodging: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,249.17 |
| Travel and Lodging | $165.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,531.86 | 2021-2025 | Intellis Adaptivestim, Synchromedii |
| Spinal Simplicity, LLC | $1,530.87 | 2021 | |
| Boston Scientific Corporation | $185.90 | 2024-2025 | Wavewriter Alpha Prime 16, Click, General - Pain Management |
| Relievant Medsystems, INC. | $149.71 | 2022 | |
| Zimvie INC. | $125.36 | 2022 | |
| Abbvie INC. | $26.47 | 2021 | |
| Globus Medical, INC. | $26.35 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $22.17 | 2025 | |
| Saluda Medical Americas, INC. | $14.07 | 2023 | Evoke Scs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.